Tress Capital has made a strategic investment in iCAN Israel-Cannabis to enhance collaboration and expand their presence in the global cannabis market.

Target Information

iCAN Israel-Cannabis, based in Israel, is at the forefront of the medical cannabis industry, specializing in research and development. The company has been instrumental in advancing the global cannabis ecosystem through innovative practices and fostering partnerships. iCAN is actively involved in various cannabis-related ventures and remains committed to promoting the safe, responsible expansion of the cannabis sector.

Industry Overview in Israel

Israel is recognized as a leader in medical cannabis research, having established a robust regulatory framework that supports the cultivation and use of medical cannabis. The nation's experience in the sector has made it an attractive destination for investment and collaboration within the global cannabis market.

Every year, Tel Aviv hosts the CannaTech conference, an influential event that draws prominent industry leaders, medical professionals, and startups. This conference serves as a platform